ESTA
Establishment LabsDNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Successful regulatory outcomes, faster international reimbursement/adoption, and scale-driven margin expansion lead to >30% upside within 12 months.
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -2.8.
What can break
Regulatory setbacks, adverse clinical/safety findings, or manufacturing breakdowns that materially slow adoption and compress margins push shares substantially lower.
Momentum
81
Value
36
Sentiment
15
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.25 · Bull $3.00 · Bear $1.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2025-12-07 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $89.78
Why
Momentum81 · Δ7d -2.8
Value36 · Δ7d -0.0
Sentiment15 · Δ7d 0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
81
34% active weight
Current posture
7d trendSoftening
Δ7d
-2.8
Δ21d
+4.3
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
15
33% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade D. Momentum 81.0 / Value 36.4 / Sentiment 14.7
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$2.07B
Beta
0.99
Shares Out
29.06M
P/E (TTM) · Derived
-41.4
P/S (TTM)
10.11
P/FCF (TTM) · Derived
-26.64
Rev YoY
+33.7%
EPS YoY
+36.3%
Gross Margin
+68.7%
Op Margin
-28.1%
Net Debt
$129.23M
Current Ratio
3.33
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology